Home > Sciences De La Vie > Industrie Pharmaceutique > Vitamines Et Suppléments > OTC Healthcare in Belgium to ...
AUTRES RESSOURCES
 
AUTRES SECTEURS
 
TOUS NOS SECTEURS
 
Vitamines Et Suppléments > Etude de marché sectorielle
 OTC Healthcare in Belgium to 2010
€ 396,00
Editeur :
Datamonitor
Langue :
Anglais
Date de publication :
Février 2007
Taille du document :
161
Autres informations :
Description , Table des matières
 
Recevez cette publication aujourd'hui !
Plus d'information ?
09 70 463 423
 
Rechercher d'autres rapports et études à commander

Rechercher et commander ici parmi 50.000 études de marché publiées par les principaux instituts d'études internationaux


Rapports privés en relation
Functional Foods and Drinks
757 pages | Juin 2006 |
This report analyzes the worldwide markets for Functional Foods and Drinks in US$ Million.
The major product segments analyzed are Cereals and Grains, Beverages, Dairy Products, and Snacks.
The
3 160,00 €
 
 
Global market review of diet trends and weight management – forecasts to 2012
96 pages | Septembre 2006 |
Global market review of diet trends and weight management – forecasts to 2012This exclusive report from just-food provides insight into the developing and controversial industry of dieting and weight
767,00 €
 
 
UK Vitamin & Dietary Supplements 2004
12 pages | Juillet 2004 |
Snapdata's UK Vitamin & Dietary Supplements 2004 report provides 2003 year-end market data, with 2004 estimates and five-year forecasts.
The report gives an instant overview of the UK vitamin and d
240,00 €
 
 
Nutraceuticals in the United States
17 pages | Novembre 2004 |
Datamonitor's Nutraceuticals in the United States industry profile is an essential resource for top-level data and analysis covering the nutraceuticals industry.
It includes data on market size and
160,00 €
 
 
Cosmeceuticals
305 pages | Octobre 2006 |
This comprehensive study analyzes the US market for cosmeceutical products and chemicals.
The term “cosmeceuticals” is a relatively new concept and as yet does not have a universally accepted defi
3 520,00 €
 
 
Production and Market of Feed Grade Amino Acids in China
32 pages | Avril 2001 |
Owing to the technical support of research institutes and the guide from the central government, the amino acid growing at a fast speed, though now the most popular method in China, the fermentation m
2 000,00 €
 
 
Nutraceuticals in Europe
17 pages | Novembre 2004 |
Datamonitor's Nutraceuticals in Europe industry profile is an essential resource for top-level data and analysis covering the nutraceuticals industry.
It includes data on market size and segmentati
160,00 €
 
 
OTC Healthcare in Belgium to 2010
161 pages | Février 2007 |
IntroductionThis databook is a detailed information resource covering all the key data points on OTC Healthcare in Belgium.
It includes comprehensive value volume segmentation and market share data
396,00 €
 
 
OTC Healthcare in Austria to 2010
162 pages | Février 2007 |
IntroductionThis databook is a detailed information resource covering all the key data points on OTC Healthcare in Austria.
It includes comprehensive value volume segmentation and market share data
396,00 €
 
 
OTC Vitamins and Dietary Supplements: France
10 pages | Juin 2005 |
Euromonitor International’s ‘OTC Vitamins and Dietary Supplements in France' Major Market Profile report offers an introduction to the market.
It is c.
10 pages long and provides a top line ove
198,00 €
 
 
 
Autres secteurs en relation
Rechercher d'autres rapports!
 
 
 
Présentation de l'étude de marché - Description & Table des matières
 OTC Healthcare in Belgium to 2010

Introduction

This databook is a detailed information resource covering all the key data points on OTC Healthcare in Belgium. It includes comprehensive value volume segmentation and market share data. The databook supplies actual data to 2005 and full forecasts to 2010.

Scope

  • Contains information on:Analgesics,Cough & cold,Indigestion,Medicated skin products,Traditional medicines,Vitamins & Other OTC healthcare products.
  • Provides market value, volume, expenditure and consumption data by market, segment and subsegment.
  • Includes company and brand share data by category, as well as distribution channel data.
  • Contains market value segmentation by demographic and socioeconomic group.


  • Highlights

    The market for OTC Healthcare in Belgium increased between 2000-2005, growing at an average annual rate of 1.7%.

    The leading company in the market in 2005 was Omega Pharma NV. The second-largest player was Novartis AG with Pfizer Inc in third place.

    Reasons to Purchase

  • Discover the major quantitative trends affecting the OTC Healthcare markets.
  • Understand consumers' consumption and expenditure patterns.
  • Understand the future direction of the market with reliable historical data and full five year forecasting.


  •  

    TABLE OF CONTENTS
    ABOUT DATAMONITOR 2
    TABLE OF CONTENTS 3
    LIST OF TABLES 7
    LIST OF FIGURES 18
    CHAPTER 1 INTRODUCTION 20
    What is this report about? 20
    How to use this report 20
    Definitions 20
    CHAPTER 2 BELGUIM OTC HEALTHCARE 25
    2.1 Value 25
    2.2 Market Share 33
    2.3 Distribution 39
    2.4 Expenditure & consumption per head 40
    2.5 ConsumerGraphics 44
    CHAPTER 3 BELGUIM ANALGESICS 47
    3.1 Value 47
    3.2 Market Share 52
    3.3 Distribution 54
    3.4 Expenditure & consumption per head 55
    3.5 ConsumerGraphics 57
    CHAPTER 4 BELGUIM COUGH AND COLD PREPARATIONS 60
    4.1 Value 60
    4.2 Market Share 66
    4.3 Distribution 68
    4.4 Expenditure & consumption per head 69
    4.5 ConsumerGraphics 72
    CHAPTER 5 BELGUIM INDIGESTION PREPARATIONS 75
    5.1 Value 75
    5.2 Market Share 80
    5.3 Distribution 82
    5.4 Expenditure & consumption per head 83
    5.5 ConsumerGraphics 85
    CHAPTER 6 BELGUIM MEDICATED SKIN PRODUCTS 88
    6.1 Value 88
    6.2 Market Share 94
    6.3 Distribution 96
    6.4 Expenditure & consumption per head 97
    6.5 ConsumerGraphics 100
    CHAPTER 7 BELGUIM TRADITIONAL MEDICINES 103
    7.1 Value 103
    7.2 Market Share 107
    7.3 Distribution 109
    7.4 Expenditure & consumption per head 110
    7.5 ConsumerGraphics 112
    CHAPTER 8 BELGUIM VITAMINS AND MINERALS 115
    8.1 Value 115
    8.2 Market Share 121
    8.3 Distribution 123
    8.4 Expenditure & consumption per head 124
    8.5 ConsumerGraphics 126
    CHAPTER 9 BELGUIM OTHER OTC HEALTHCARE 129
    9.1 Value 129
    9.2 Market Share 135
    9.3 Distribution 139
    9.4 Expenditure & consumption per head 140
    9.5 ConsumerGraphics 143
    CHAPTER 10 BELGUIM SOCIOECONOMIC PROFILE 146
    10.1 Country Overview 146
    10.2 Key Facts 147
    10.3 Political Overview 148
    10.4 Belgium Economic Overview 149
    CHAPTER 11 BELGUIM MACROECONOMIC PROFILE 150
    11.1 Macroeconomic Indicators 150
    CHAPTER 12 RESEARCH METHODOLOGY 156
    12.1 Methodology overview 156
    12.2 Secondary research 157
    12.3 Market modelling 158
    12.4 Primary research 159
    12.5 Data finalisation 160
    12.6 Ongoing research 160
    CHAPTER 13 APPENDIX 161
    13.1 Future readings 161
    13.2 How to contact experts in your industry 161

    LIST OF TABLES
    Table 1: OTC Healthcare category definitions 21
    Table 2: OTC Healthcare distribution channels 23
    Table 3: Belguim OTC Healthcare value, 2000-2005 (EUR m, 2005 prices) 25
    Table 4: Belguim OTC Healthcare value forecast, 2005-2010 (EUR m, 2005 prices) 26
    Table 5: Belguim OTC Healthcare value, 2000-2005 (EUR m, nominal prices) 28
    Table 6: Belguim OTC Healthcare value forecast, 2005-2010 (EUR m, nominal prices) 29
    Table 7: Belguim OTC Healthcare value, 2000-2005 (US$ m nominal prices) 30
    Table 8: Belguim OTC Healthcare value forecast, 2005-2010 (US$ m nominal prices) 31
    Table 9: Belguim OTC Healthcare brand share, by value, 2004-2005 (%) 33
    Table 10: Belguim OTC Healthcare value, by brand, 2004-2005 (EUR m nominal prices) 35
    Table 11: Belguim OTC Healthcare company share, by value, 2004-2005 (%) 37
    Table 12: Belguim OTC Healthcare value, by company, 2004-2005 (EUR m nominal prices) 38
    Table 13: Belguim OTC Healthcare distribution channels, by value, 2004-2005 (%) 39
    Table 14: Belguim OTC Healthcare value, by distribution channel, 2004-2005 (EUR m nominal prices) 39
    Table 15: Belguim OTC Healthcare expenditure per head, 2000-2005 (EUR, 2005 prices) 40
    Table 16: Belguim OTC Healthcare forecast expenditure per head, 2005-2010 (EUR, 2005 prices) 41
    Table 17: Belguim OTC Healthcare expenditure per head, 2000-2005 (US$ nominal prices) 42
    Table 18: Belguim OTC Healthcare forecast expenditure per head, 2005-2010 (US$ nominal prices) 43
    Table 19: Belguim OTC Healthcare value, by age group, 2005 44
    Table 20: Belguim OTC Healthcare value, by income group, 2005 44
    Table 21: Belguim OTC Healthcare value, by gender, 2005 45
    Table 22: Belguim OTC Healthcare value, by marital status, 2005 45
    Table 23: Belguim OTC Healthcare value, by size of household, 2005 45
    Table 24: Belguim OTC Healthcare value, by region, 2005 46
    Table 25: Belguim OTC Healthcare value, by urban/rural residence, 2005 46
    Table 26: Belguim Analgesics value, 2000-2005 (EUR m, 2005 prices) 47
    Table 27: Belguim Analgesics value forecast, 2005-2010 (EUR m, 2005 prices) 47
    Table 28: Belguim Analgesics value, 2000-2005 (EUR m, nominal prices) 49
    Table 29: Belguim Analgesics value forecast, 2005-2010 (EUR m, nominal prices) 49
    Table 30: Belguim Analgesics value, 2000-2005 (US$ m nominal prices) 50
    Table 31: Belguim Analgesics value forecast, 2005-2010 (US$ m nominal prices) 50
    Table 32: Belguim Analgesics brand share, by value, 2004-2005 (%) 52
    Table 33: Belguim Analgesics value, by brand, 2004-2005 (EUR m nominal prices) 52
    Table 34: Belguim Analgesics company share, by value, 2004-2005 (%) 53
    Table 35: Belguim Analgesics value, by company, 2004-2005 (EUR m nominal prices) 53
    Table 36: Belguim Analgesics distribution channels, by value, 2004-2005 (%) 54
    Table 37: Belguim Analgesics value, by distribution channel, 2004-2005 (EUR m nominal prices) 54
    Table 38: Belguim Analgesics expenditure per head, 2000-2005 (EUR, 2005 prices) 55
    Table 39: Belguim Analgesics forecast expenditure per head, 2005-2010 (EUR, 2005 prices) 55
    Table 40: Belguim Analgesics expenditure per head, 2000-2005 (US$ nominal prices) 56
    Table 41: Belguim Analgesics forecast expenditure per head, 2005-2010 (US$ nominal prices) 56
    Table 42: Belguim Analgesics value, by age group, 2005 57
    Table 43: Belguim Analgesics value, by income group, 2005 57
    Table 44: Belguim Analgesics value, by gender, 2005 58
    Table 45: Belguim Analgesics value, by marital status, 2005 58
    Table 46: Belguim Analgesics value, by size of household, 2005 58
    Table 47: Belguim Analgesics value, by region, 2005 59
    Table 48: Belguim Analgesics value, by urban/rural residence, 2005 59
    Table 49: Belguim Cough and cold preparations value, 2000-2005 (EUR m, 2005 prices) 60
    Table 50: Belguim Cough and cold preparations value forecast, 2005-2010 (EUR m, 2005 prices) 61
    Table 51: Belguim Cough and cold preparations value, 2000-2005 (EUR m, nominal prices) 63
    Table 52: Belguim Cough and cold preparations value forecast, 2005-2010 (EUR m, nominal prices) 63
    Table 53: Belguim Cough and cold preparations value, 2000-2005 (US$ m nominal prices) 64
    Table 54: Belguim Cough and cold preparations value forecast, 2005-2010 (US$ m nominal prices) 64
    Table 55: Belguim Cough and cold preparations brand share, by value, 2004-2005 (%) 66
    Table 56: Belguim Cough and cold preparations value, by brand, 2004-2005 (EUR m nominal prices) 66
    Table 57: Belguim Cough and cold preparations company share, by value, 2004-2005 (%) 67
    Table 58: Belguim Cough and cold preparations value, by company, 2004-2005 (EUR m nominal prices) 67
    Table 59: Belguim Cough and cold preparations distribution channels, by value, 2004-2005 (%) 68
    Table 60: Belguim Cough and cold preparations value, by distribution channel, 2004-2005 (EUR m nominal prices) 68
    Table 61: Belguim Cough and cold preparations expenditure per head, 2000-2005 (EUR, 2005 prices) 69
    Table 62: Belguim Cough and cold preparations forecast expenditure per head, 2005-2010 (EUR, 2005 prices) 70
    Table 63: Belguim Cough and cold preparations expenditure per head, 2000-2005 (US$ nominal prices) 71
    Table 64: Belguim Cough and cold preparations forecast expenditure per head, 2005-2010 (US$ nominal prices) 71
    Table 65: Belguim Cough and cold preparations value, by age group, 2005 72
    Table 66: Belguim Cough and cold preparations value, by income group, 2005 72
    Table 67: Belguim Cough and cold preparations value, by gender, 2005 73
    Table 68: Belguim Cough and cold preparations value, by marital status, 2005 73
    Table 69: Belguim Cough and cold preparations value, by size of household, 2005 73
    Table 70: Belguim Cough and cold preparations value, by region, 2005 74
    Table 71: Belguim Cough and cold preparations value, by urban/rural residence, 2005 74
    Table 72: Belguim Indigestion preparations value, 2000-2005 (EUR m, 2005 prices) 75
    Table 73: Belguim Indigestion preparations value forecast, 2005-2010 (EUR m, 2005 prices) 75
    Table 74: Belguim Indigestion preparations value, 2000-2005 (EUR m, nominal prices) 77
    Table 75: Belguim Indigestion preparations value forecast, 2005-2010 (EUR m, nominal prices) 77
    Table 76: Belguim Indigestion preparations value, 2000-2005 (US$ m nominal prices) 78
    Table 77: Belguim Indigestion preparations value forecast, 2005-2010 (US$ m nominal prices) 78
    Table 78: Belguim Indigestion preparations brand share, by value, 2004-2005 (%) 80
    Table 79: Belguim Indigestion preparations value, by brand, 2004-2005 (EUR m nominal prices) 80
    Table 80: Belguim Indigestion preparations company share, by value, 2004-2005 (%) 81
    Table 81: Belguim Indigestion preparations value, by company, 2004-2005 (EUR m nominal prices) 81
    Table 82: Belguim Indigestion preparations distribution channels, by value, 2004-2005 (%) 82
    Table 83: Belguim Indigestion preparations value, by distribution channel, 2004-2005 (EUR m nominal prices) 82
    Table 84: Belguim Indigestion preparations expenditure per head, 2000-2005 (EUR, 2005 prices) 83
    Table 85: Belguim Indigestion preparations forecast expenditure per head, 2005-2010 (EUR, 2005 prices) 83
    Table 86: Belguim Indigestion preparations expenditure per head, 2000-2005 (US$ nominal prices) 84
    Table 87: Belguim Indigestion preparations forecast expenditure per head, 2005-2010 (US$ nominal prices) 84
    Table 88: Belguim Indigestion preparations value, by age group, 2005 85
    Table 89: Belguim Indigestion preparations value, by income group, 2005 85
    Table 90: Belguim Indigestion preparations value, by gender, 2005 86
    Table 91: Belguim Indigestion preparations value, by marital status, 2005 86
    Table 92: Belguim Indigestion preparations value, by size of household, 2005 86
    Table 93: Belguim Indigestion preparations value, by region, 2005 87
    Table 94: Belguim Indigestion preparations value, by urban/rural residence, 2005 87
    Table 95: Belguim Medicated skin products value, 2000-2005 (EUR m, 2005 prices) 88
    Table 96: Belguim Medicated skin products value forecast, 2005-2010 (EUR m, 2005 prices) 89
    Table 97: Belguim Medicated skin products value, 2000-2005 (EUR m, nominal prices) 91
    Table 98: Belguim Medicated skin products value forecast, 2005-2010 (EUR m, nominal prices) 91
    Table 99: Belguim Medicated skin products value, 2000-2005 (US$ m nominal prices) 92
    Table 100: Belguim Medicated skin products value forecast, 2005-2010 (US$ m nominal prices) 92
    Table 101: Belguim Medicated skin products brand share, by value, 2004-2005 (%) 94
    Table 102: Belguim Medicated skin products value, by brand, 2004-2005 (EUR m nominal prices) 94
    Table 103: Belguim Medicated skin products company share, by value, 2004-2005 (%) 95
    Table 104: Belguim Medicated skin products value, by company, 2004-2005 (EUR m nominal prices) 95
    Table 105: Belguim Medicated skin products distribution channels, by value, 2004-2005 (%) 96
    Table 106: Belguim Medicated skin products value, by distribution channel, 2004-2005 (EUR m nominal prices) 96
    Table 107: Belguim Medicated skin products expenditure per head, 2000-2005 (EUR, 2005 prices) 97
    Table 108: Belguim Medicated skin products forecast expenditure per head, 2005-2010 (EUR, 2005 prices) 98
    Table 109: Belguim Medicated skin products expenditure per head, 2000-2005 (US$ nominal prices) 99
    Table 110: Belguim Medicated skin products forecast expenditure per head, 2005-2010 (US$ nominal prices) 99
    Table 111: Belguim Medicated skin products value, by age group, 2005 100
    Table 112: Belguim Medicated skin products value, by income group, 2005 100
    Table 113: Belguim Medicated skin products value, by gender, 2005 101
    Table 114: Belguim Medicated skin products value, by marital status, 2005 101
    Table 115: Belguim Medicated skin products value, by size of household, 2005 101
    Table 116: Belguim Medicated skin products value, by region, 2005 102
    Table 117: Belguim Medicated skin products value, by urban/rural residence, 2005 102
    Table 118: Belguim Traditional medicines value, 2000-2005 (EUR m, 2005 prices) 103
    Table 119: Belguim Traditional medicines value forecast, 2005-2010 (EUR m, 2005 prices) 103
    Table 120: Belguim Traditional medicines value, 2000-2005 (EUR m, nominal prices) 105
    Table 121: Belguim Traditional medicines value forecast, 2005-2010 (EUR m, nominal prices) 105
    Table 122: Belguim Traditional medicines value, 2000-2005 (US$ m nominal prices) 106
    Table 123: Belguim Traditional medicines value forecast, 2005-2010 (US$ m nominal prices) 106
    Table 124: Belguim Traditional medicines brand share, by value, 2004-2005 (%) 107
    Table 125: Belguim Traditional medicines value, by brand, 2004-2005 (EUR m nominal prices) 107
    Table 126: Belguim Traditional medicines company share, by value, 2004-2005 (%) 108
    Table 127: Belguim Traditional medicines value, by company, 2004-2005 (EUR m nominal prices) 108
    Table 128: Belguim Traditional medicines distribution channels, by value, 2004-2005 (%) 109
    Table 129: Belguim Traditional medicines value, by distribution channel, 2004-2005 (EUR m nominal price) 109
    Table 130: Belguim Traditional medicines expenditure per head, 2000-2005 (EUR, 2005 prices) 110
    Table 131: Belguim Traditional medicines forecast expenditure per head, 2005-2010 (EUR, 2005 prices) 110
    Table 132: Belguim Traditional medicines expenditure per head, 2000-2005 (US$ nominal prices) 111
    Table 133: Belguim Traditional medicines forecast expenditure per head, 2005-2010 (US$ nominal prices) 111
    Table 134: Belguim Traditional medicines value, by age group, 2005 112
    Table 135: Belguim Traditional medicines value, by income group, 2005 112
    Table 136: Belguim Traditional medicines value, by gender, 2005 113
    Table 137: Belguim Traditional medicines value, by marital status, 2005 113
    Table 138: Belguim Traditional medicines value, by size of household, 2005 113
    Table 139: Belguim Traditional medicines value, by region, 2005 114
    Table 140: Belguim Traditional medicines value, by urban/rural residence, 2005 114
    Table 141: Belguim Vitamins and minerals value, 2000-2005 (EUR m, 2005 prices) 115
    Table 142: Belguim Vitamins and minerals value forecast, 2005-2010 (EUR m, 2005 prices) 116
    Table 143: Belguim Vitamins and minerals value, 2000-2005 (EUR m, nominal prices) 118
    Table 144: Belguim Vitamins and minerals value forecast, 2005-2010 (EUR m, nominal prices) 118
    Table 145: Belguim Vitamins and minerals value, 2000-2005 (US$ m nominal prices) 119
    Table 146: Belguim Vitamins and minerals value forecast, 2005-2010 (US$ m nominal prices) 119
    Table 147: Belguim Vitamins and minerals brand share, by value, 2004-2005 (%) 121
    Table 148: Belguim Vitamins and minerals value, by brand, 2004-2005 (EUR m nominal prices) 121
    Table 149: Belguim Vitamins and minerals company share, by value, 2004-2005 (%) 122
    Table 150: Belguim Vitamins and minerals value, by company, 2004-2005 (EUR m nominal prices) 122
    Table 151: Belguim Vitamins and minerals distribution channels, by value, 2004-2005 (%) 123
    Table 152: Belguim Vitamins and minerals value, by distribution channel, 2004-2005 (EUR m nominal price) 123
    Table 153: Belguim Vitamins and minerals expenditure per head, 2000-2005 (EUR, 2005 prices) 124
    Table 154: Belguim Vitamins and minerals forecast expenditure per head, 2005-2010 (EUR, 2005 prices) 124
    Table 155: Belguim Vitamins and minerals expenditure per head, 2000-2005 (US$ nominal prices) 125
    Table 156: Belguim Vitamins and minerals forecast expenditure per head, 2005-2010 (US$ nominal prices) 125
    Table 157: Belguim Vitamins and minerals value, by age group, 2005 126
    Table 158: Belguim Vitamins and minerals value, by income group, 2005 126
    Table 159: Belguim Vitamins and minerals value, by gender, 2005 127
    Table 160: Belguim Vitamins and minerals value, by marital status, 2005 127
    Table 161: Belguim Vitamins and minerals value, by size of household, 2005 127
    Table 162: Belguim Vitamins and minerals value, by region, 2005 128
    Table 163: Belguim Vitamins and minerals value, by urban/rural residence, 2005 128
    Table 164: Belguim Other OTC healthcare value, 2000-2005 (EUR m, 2005 prices) 129
    Table 165: Belguim Other OTC healthcare value forecast, 2005-2010 (EUR m, 2005 prices) 130
    Table 166: Belguim Other OTC healthcare value, 2000-2005 (EUR m, nominal prices) 132
    Table 167: Belguim Other OTC healthcare value forecast, 2005-2010 (EUR m, nominal prices) 132
    Table 168: Belguim Other OTC healthcare value, 2000-2005 (US$ m nominal prices) 133
    Table 169: Belguim Other OTC healthcare value forecast, 2005-2010 (US$ m nominal prices) 133
    Table 170: Belguim Other OTC healthcare brand share, by value, 2004-2005 (%) 135
    Table 171: Belguim Other OTC healthcare value, by brand, 2004-2005 (EUR m nominal prices) 136
    Table 172: Belguim Other OTC healthcare company share, by value, 2004-2005 (%) 137
    Table 173: Belguim Other OTC healthcare value, by company, 2004-2005 (EUR m nominal prices) 138
    Table 174: Belguim Other OTC healthcare distribution channels, by value, 2004-2005 (%) 139
    Table 175: Belguim Other OTC healthcare value, by distribution channel, 2004-2005 (EUR m nominal prices) 139
    Table 176: Belguim Other OTC healthcare expenditure per head, 2000-2005 (EUR, 2005 prices) 140
    Table 177: Belguim Other OTC healthcare forecast expenditure per head, 2005-2010 (EUR, 2005 prices) 141
    Table 178: Belguim Other OTC healthcare expenditure per head, 2000-2005 (US$ nominal prices) 142
    Table 179: Belguim Other OTC healthcare forecast expenditure per head, 2005-2010 (US$ nominal prices) 142
    Table 180: Belguim Other OTC healthcare value, by age group, 2005 143
    Table 181: Belguim Other OTC healthcare value, by income group, 2005 143
    Table 182: Belguim Other OTC healthcare value, by gender, 2005 144
    Table 183: Belguim Other OTC healthcare value, by marital status, 2005 144
    Table 184: Belguim Other OTC healthcare value, by size of household, 2005 144
    Table 185: Belguim Other OTC healthcare value, by region, 2005 145
    Table 186: Belguim Other OTC healthcare value, by urban/rural residence, 2005 145
    Table 187: Belgium Key Facts 147
    Table 188: Belgium population, by age group, 2000-2005 (millions) 150
    Table 189: Belgium population forecast, by age group, 2005-2010 (millions) 151
    Table 190: Belgium population, by gender, 2000-2005 (millions) 151
    Table 191: Belgium population forecast, by gender, 2005-2010 (millions) 152
    Table 192: Belgium real GDP, 2000-2005 (EUR bn, 2005 prices) 152
    Table 193: Belgium real GDP forecast, 2005-2010 (EUR bn, 2005 prices) 152
    Table 194: Belgium nominal GDP, 2000-2005 (EUR bn, nominal prices) 153
    Table 195: Belgium nominal GDP forecast, 2005-2010 (EUR bn, nominal prices) 153
    Table 196: Belgium real GDP, 2000-2005 (US$ bn, 2005 prices) 153
    Table 197: Belgium real GDP forecast, 2005-2010 (US$ bn, 2005 prices) 154
    Table 198: Belgium consumer price index, 2000-2005 (2000=100) 154
    Table 199: Belgium consumer price index, 2005-2010 (2000=100) 154
    Table 200: Belgium exchange rate, 2000-2005 155


    LIST OF FIGURES
    Figure 1: Belguim OTC Healthcare value & value forecast, 2000-2010 (EUR m, 2005 prices) 27
    Figure 2: Belguim OTC Healthcare category growth comparison, by value, 2000-2010 32
    Figure 3: Belguim Analgesics value & value forecast, 2000-2010 (EUR m, 2005 prices) 48
    Figure 4: Belguim Analgesics segment growth comparison, by value, 2000-2010 51
    Figure 5: Belguim Cough and cold preparations value & value forecast, 2000-2010 (EUR m, 2005 prices) 62
    Figure 6: Belguim Cough and cold preparations segment growth comparison, by value, 2000-2010 65
    Figure 7: Belguim Indigestion preparations value & value forecast, 2000-2010 (EUR m, 2005 prices) 76
    Figure 8: Belguim Indigestion preparations segment growth comparison, by value, 2000-2010 79
    Figure 9: Belguim Medicated skin products value & value forecast, 2000-2010 (EUR m, 2005 prices) 90
    Figure 10: Belguim Medicated skin products segment growth comparison, by value, 2000-2010 93
    Figure 11: Belguim Traditional medicines value & value forecast, 2000-2010 (EUR m, 2005 prices) 104
    Figure 12: Belguim Vitamins and minerals value & value forecast, 2000-2010 (EUR m, 2005 prices) 117
    Figure 13: Belguim Vitamins and minerals segment growth comparison, by value, 2000-2010 120
    Figure 14: Belguim Other OTC healthcare value & value forecast, 2000-2010 (EUR m, 2005 prices) 131
    Figure 15: Belguim Other OTC healthcare segment growth comparison, by value, 2000-2010 134
    Figure 16: Map of Belgium 147
    Figure 17: Annual data review process 157



    New Search:

    PPLSEN